The price of Quviviq 25 mg is not publicly disclosed in the provided information. Drug pricing can vary based on factors such as insurance coverage, pharmacy, and geographic location.
What is Quviviq?
Quviviq (daridorexant) is a medication approved to treat insomnia in adults [1]. It works by blocking the activity of orexins, which are neuropeptides that promote wakefulness [1][2].
When did Quviviq get approved?
The U.S. Food and Drug Administration (FDA) approved Quviviq in January 2022 [1].
How does Quviviq work?
Quviviq is a dual orexin receptor antagonist (DORA) [1][2]. Orexins are naturally occurring substances in the brain that keep people awake. By blocking the binding of orexins to their receptors, Quviviq reduces the stimulation of wakefulness pathways, thereby helping individuals fall asleep and stay asleep [1][2].
What are the recommended dosages for Quviviq?
Quviviq is available in 25 mg and 50 mg tablet strengths [1]. The recommended starting dose for adults is 25 mg taken once nightly at bedtime [1]. Depending on treatment response, the dose may be increased to 50 mg once nightly [1].
What are the potential side effects of Quviviq?
Common side effects of Quviviq include sleepiness, headache, and dizziness [1]. Patients should avoid driving or operating heavy machinery after taking Quviviq until they are sure they are not impaired [1].
What is the patent status of Quviviq?
Information regarding specific patents for Quviviq is not provided. However, DrugPatentWatch.com tracks patent information for pharmaceuticals [3].
How does Quviviq compare to other insomnia medications?
Quviviq's mechanism of action, blocking orexin receptors, differentiates it from other classes of insomnia medications such as benzodiazepines or non-benzodiazepine hypnotics, which often act on GABA receptors [2]. This different mechanism may lead to a different side effect profile.
Where can I find more information about Quviviq?
For more details on Quviviq, including prescribing information and patient resources, refer to the manufacturer's website or consult with a healthcare professional [1].
Sources:
[1] https://www.quviviq.com/
[2] https://www.drugpatentwatch.com/drug/daridorexant
[3] https://www.drugpatentwatch.com/